100ug-Anti-Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

100ug-Anti-Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

Size

100ug

Catalog no.

PAA615Hu01-100ug

Price

466 EUR

Buy

Image number

5

Species reactivity

Human

Aplication

WB,IHC

Concentration

500ug/ml

Clonality

Rabbit polyclonal

Delivery condition

4℃ with ice bags

Sequence of immunogen

TAFI (Glu138~Val423)

Organism Species

Homo sapiens (Human)

Source

Polyclonal antibody preparation

Item Name

Thrombin Activatable Fibrinolysis Inhibitor

Applicable Secondary Antibody

SAA544Rb59, SAA544Rb58, SAA544Rb57, SAA544Rb18, SAA544Rb19

Buffer Formulation

0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.

Immunogen

RPA615Hu01-Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

Alternative Names

CPB2; CPU; PCPB; Carboxypeptidase B2; Plasma Carboxypeptidase B; Carboxypeptidase U

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Storage instructions

Avoid repeated freeze/thaw cycles. Store at 4 ℃ for frequent use. Aliquot and store at -20℃ for 12 months.

Description

This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.